Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover how using coupons for grocery cash back can help you save more on your grocery purchases. Start using coupons today!
22,116 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
Arm Holdings stunned markets with a powerful run, then pulled back after earnings. This guide breaks down whether thi...
Figma trades higher ahead of tonight’s Q1 print, as analysts eye revenue growth and AI momentum. Live coverage tracks...
Citi lifts Coca-Cola's price target to $91 from $90, citing the World Cup marketing push as a key catalyst. The move ...
As 2026 unfolds, retirees face tax and market challenges. A seasoned advisor outlines a tax-smart playbook for a $2 m...
NVIDIA is more than a chip maker; it’s the AI backbone for modern computing. This guide explains why NVIDIA still art...
SpaceX’s long-anticipated S-1 lays out revenue and losses, yet key subscription and launch-cost details are absent, c...
An affluent California couple in their 70s plans a major renovation. Months later, they confront a surprising, steep ...
When headlines shift at the Fed, markets tend to move fast. This piece breaks down how Warsh becoming Fed Chair could...
As a new Fed chair, chair kevin warsh will confront two high-stakes tests in just 100 days. One test centers on polit...